Stakeholder comments on the Senate drug pricing discussion draft are due to the Health, Education, Labor and Pensions Committee by 5 June. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
